Rheumatoid Arthritis
Conditions
Brief summary
This is an epidemiological, multicenter, retrospective study to analyze the management of rheumatoid arthritis (RA) in usual clinical practice in Spain. Two groups of patients will be analyzed: individuals who have had RA for two years or less (the early RA group) and individuals who have had RA for more than 2 years and who currently meet the ACR criteria for RA (the established RA group).
Interventions
None listed
Sponsors
Wyeth is now a wholly owned subsidiary of Pfizer
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Group 1: early RA : patients with disease lasting 2 years or less, considered by the investigator as an early RA * Group 2: established RA: patients with disease lasting more than 2 years who meet the ACR criteria for RA
Exclusion criteria
* Patients with any rheumatic disease different from RA * Participation in any clinical trial or study in the last 12 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapeutic management of the RA (actual and 12 month follow-up) in a real-world setting. Descriptive analysis of sociodemographics and clinical variables for patients and sorted by group (early and established RA) for the last 12 months | 12 months |
Secondary
| Measure | Time frame |
|---|---|
| Measurements of diagnostic and outcomes used in the common clinical practice. Degree of follow-up of the actual Spanish consensus on clinical and therapeutic management of patients with RA | 12 months |
Outcome results
None listed